BioSpace News Archive

DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that its management will participate at the following upcoming investor conferences: Cowen 41 st Annual Healthcare Conference Presenting on Wednesday, March 3, 2021 at 3:20 p.m. Eastern Time

Southwest Research Institute announced consolidated revenues of nearly $696 million in fiscal year 2020, up more than 3% from 2019 and the highest ever recorded by the Institute.

Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat at the 10 th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 10:00 am ET.

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced the completion of its previously announced underwritten public offering of 9,783,660 shares of its common stock, which includes 1,212,231 shares of common stock pursuant to the underwriters’ partial exercise of their option to purchase additional shares of common stock, at a price to the public of $3.50 per share. All shares in the offeri

Bioprocess container is a single-use flexible container utilized for critical sterile liquid-handling applications in the biopharmaceutical industry.

Catheter is a flexible and thin tube made up of medical grade materials to serve variety of functions including access by surgical instruments, drainage, and administration of fluids or gases.

ICE is a form of echocardiography that is carried out using catheters. ICE gathers images from inside the heart, rather than by sending sound waves through the chest wall.

Lately, miRNA sequencing and assay is gaining traction in the global miRNA sequencing and assay market.

Opioids are used for pain relief. They have a depressant effect on the central nervous system as well as the potential to cause euphoria.

The growth of the cell lysis and disruption market can be attributable to the large adoption of cell lysis and disruption methods during manufacture of bio-therapeutics and animal-based products.